Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1475Neoplasms 996Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 682Stomach Neoplasms 646Lung Neoplasms 583Prostatic Neoplasms 543Pancreatic Neoplasms 457Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 289Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 276Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 240Multiple Myeloma 232Brain Neoplasms 203Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 191Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 140

Interventions

Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × OTHER × Granuloma, Giant Cell × Clear all
NCT03605199 2019-08-26

Denosumab in Subjects With Giant Cell Rich Tumors of Bone

Leiden University Medical Center

Phase 2 Unknown
60 enrolled

Chondroblastoma, Granuloma, Giant Cell, Bone Cysts, Aneurysmal, Osteoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡